MoneyWorks4Me

Ajanta Pharma informs about press release

14 Jun 2016 Evaluate

Ajanta Pharma has informed about a Press Release dated June 14, 2016 titled ‘Ajanta Pharma Announces the Launch of Memantine Hydrochloride Tablets in US Market’.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3555.05 14.35 (0.41%)
28-Aug-2026 12:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1920.10
Dr. Reddys Labs. 1183.05
Cipla 1414.00
Lupin 2169.50
Zydus Lifesciences 1180.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: